Search Results for: Characterizing Uncertainty In The Assessment Of Benefits And Risks Of Pharmaceutical Products

Despite the extensive body of evidence that informs regulatory decisions on pharmaceutical products, significant uncertainties persist, including the underlying

On February 12, 2014, the Institute of Medicine's Forum on Drug Discovery, Development, and Translation held a public workshop as the first of a two-part series

Guides You on the Development and Implementation of B–R Evaluations Benefit–Risk Assessment Methods in Medical Product Development: Bridging Qualitative and

Representing the first collection on the topic, this book builds from foundations to case studies, to future prospects, providing the reader with a rich and com

Risk assessment has become a dominant public policy tool for making choices, based on limited resources, to protect public health and the environment. It has be